Immunocore Holdings (IMCR) Other Working Capital Changes (2023 - 2026)
Immunocore Holdings (IMCR) posted Other Working Capital Changes of -$864000.0 for Q1 2026, up 66.99% sequentially from -$2.6 million in Q4 2025, and down 214.29% YoY from $756000.0 in Q1 2025.
Immunocore Holdings (IMCR) Other Working Capital Changes (2023 - 2026) Analysis & Trends
Immunocore Holdings has reported Other Working Capital Changes for 4 years, with the latest figure at -$864000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 214.29% year-over-year to -$864000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.7 million (down 823.63% YoY) and the FY2025 annual result came in at -$2.1 million, down 27.0% from the prior year.
- Other Working Capital Changes improved to -$864000.0 in Q1 2026 per IMCR's latest filing, from -$2.6 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $27.2 million in Q4 2023 and troughed at -$18.1 million in Q1 2023.
- A 4-year average of $3.6 million and a median of $1.9 million in 2024 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 1561.11% in 2025, down 494.77% in 2025.
- Over 4 years, Other Working Capital Changes stood at -$8.7 million in 2023, then soared by 94.92% to -$440000.0 in 2024, then plunged by 494.77% to -$2.6 million in 2025, then jumped by 66.99% to -$864000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$864000.0, -$2.6 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Immunocore Holdings | 1.76 Bn | 880.92 Mn | 114.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.10 Mn |
| Jun 30, 2026 | -2.10 Mn |
| Jun 30, 2026 | -2.10 Mn |
| Mar 31, 2026 | 18.77 Mn |
| Mar 31, 2026 | 18.77 Mn |
| Mar 31, 2026 | 18.77 Mn |
| Dec 31, 2025 | 1.02 Mn |
| Dec 31, 2025 | 1.02 Mn |
| Dec 31, 2025 | 1.02 Mn |
| Sep 30, 2025 | 9.25 Mn |
| Sep 30, 2025 | 9.25 Mn |
| Sep 30, 2025 | 9.25 Mn |
| Jun 30, 2025 | -5.10 Mn |
| Jun 30, 2025 | -5.10 Mn |
| Jun 30, 2025 | -5.10 Mn |
| Mar 31, 2025 | 1.57 Mn |
| Mar 31, 2025 | 1.57 Mn |
| Mar 31, 2025 | 1.57 Mn |
| Dec 31, 2024 | 5.69 Mn |
| Dec 31, 2024 | 5.69 Mn |